IMTX
Price
$9.55
Change
+$0.17 (+1.81%)
Updated
Jan 30 closing price
Capitalization
1.28B
51 days until earnings call
Intraday BUY SELL Signals
RLAY
Price
$7.66
Change
-$0.05 (-0.65%)
Updated
Jan 30 closing price
Capitalization
1.33B
17 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMTX vs RLAY

Header iconIMTX vs RLAY Comparison
Open Charts IMTX vs RLAYBanner chart's image
Immatics
Price$9.55
Change+$0.17 (+1.81%)
Volume$571.47K
Capitalization1.28B
Relay Therapeutics
Price$7.66
Change-$0.05 (-0.65%)
Volume$1.26M
Capitalization1.33B
IMTX vs RLAY Comparison Chart in %
IMTX
Daily Signal:
Gain/Loss:
RLAY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IMTX vs. RLAY commentary
Feb 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMTX is a Hold and RLAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 02, 2026
Stock price -- (IMTX: $9.55 vs. RLAY: $7.66)
Brand notoriety: IMTX and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMTX: 122% vs. RLAY: 59%
Market capitalization -- IMTX: $1.28B vs. RLAY: $1.33B
IMTX [@Biotechnology] is valued at $1.28B. RLAY’s [@Biotechnology] market capitalization is $1.33B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.22B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMTX’s FA Score shows that 0 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • IMTX’s FA Score: 0 green, 5 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMTX’s TA Score shows that 3 TA indicator(s) are bullish while RLAY’s TA Score has 3 bullish TA indicator(s).

  • IMTX’s TA Score: 3 bullish, 6 bearish.
  • RLAY’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both IMTX and RLAY are a bad buy in the short-term.

Price Growth

IMTX (@Biotechnology) experienced а -3.63% price change this week, while RLAY (@Biotechnology) price change was +3.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.27%. For the same industry, the average monthly price growth was +3.46%, and the average quarterly price growth was +33.81%.

Reported Earning Dates

IMTX is expected to report earnings on Mar 25, 2026.

RLAY is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (-4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($1.33B) and IMTX($1.28B) have the same market capitalization . IMTX (-9.048) and RLAY (-9.456) have similar YTD gains . IMTX has higher annual earnings (EBITDA): -106.34M vs. RLAY (-322.8M). RLAY has more cash in the bank: 596M vs. IMTX (431M). IMTX has less debt than RLAY: IMTX (16.4M) vs RLAY (33.3M). IMTX has higher revenues than RLAY: IMTX (84.8M) vs RLAY (8.36M).
IMTXRLAYIMTX / RLAY
Capitalization1.28B1.33B96%
EBITDA-106.34M-322.8M33%
Gain YTD-9.048-9.45696%
P/E Ratio27.61N/A-
Revenue84.8M8.36M1,015%
Total Cash431M596M72%
Total Debt16.4M33.3M49%
FUNDAMENTALS RATINGS
IMTX: Fundamental Ratings
IMTX
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
64
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMTXRLAY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
82%
Momentum
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 12 days ago
78%
Bullish Trend 7 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
81%
Bearish Trend 18 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
IMTX
Daily Signal:
Gain/Loss:
RLAY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DEMRX39.530.44
+1.13%
Nomura Emerging Markets R
GCAVX24.65-0.11
-0.44%
GMO US Small Cap Value VI
STVZX10.20-0.06
-0.58%
Virtus Ceredex Large-Cap Value Equity R6
FTCVX38.10-0.63
-1.63%
Fidelity Advisor Convertible Secs M
PDEZX21.86-0.62
-2.76%
PGIM Jennison Emerging Markets Eq Opps Z

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with IDYA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+1.81%
IDYA - IMTX
54%
Loosely correlated
-2.42%
RLAY - IMTX
50%
Loosely correlated
-0.65%
XNCR - IMTX
49%
Loosely correlated
-2.34%
CGON - IMTX
49%
Loosely correlated
-2.56%
SYRE - IMTX
49%
Loosely correlated
-4.76%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with VIR. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-0.65%
VIR - RLAY
57%
Loosely correlated
-4.37%
NRIX - RLAY
57%
Loosely correlated
-6.08%
KURA - RLAY
54%
Loosely correlated
-1.22%
IMNM - RLAY
54%
Loosely correlated
-1.79%
XNCR - RLAY
52%
Loosely correlated
-2.34%
More